Potential determinants of vaccine hesitancy among celiac disease patients: a single cohort analysis
- PMID: 37614445
- PMCID: PMC10442556
- DOI: 10.3389/fpubh.2023.1061617
Potential determinants of vaccine hesitancy among celiac disease patients: a single cohort analysis
Abstract
Introduction: Though researchers and scholars have greatly emphasized addressing the influencing factors of vaccination hesitancy, little attention has been paid to patients with celiac disease. Addressing the variables hampering attitudes might help direct appropriate patient advocacy and doctor-patient communication endeavors to encourage vaccination among celiac disease patients. The present investigation seeks to explore the coverage against vaccine-preventable diseases, vaccination attitudes, and related possible factors among celiac disease patients in the Pakistani setting.
Methods: A self-reported online survey was conducted in Islamabad, Pakistan, for celiac disease patients aged 18 and above. The questionnaire was completed by 226 participants, with a response rate of 43.8%. The influencing variables for vaccination hesitancy were examined, and 95% confidence intervals for the crude and adjusted odds ratios were computed.
Results: Among the study population, the majority were females, with a ratio of 75.66%. A prominent proportion of 69.03% was observed for influenza vaccination, while 39.82% were unable to recall all of the vaccinations they had previously received. Only 7% of the patients were considered to have a negative attitude toward vaccination, compared to an estimated 76% who were in favor of it. The significantly positive influencing factors observed toward vaccination were being well-educated (graduate, master, or above), possible recurrence of vaccine-preventable diseases with declining vaccination coverage (adjusted OR: 13.36), and increased confidence in vaccines from health care experts compared to electronic media (adjusted OR: 8.41). Contrarily, practicing complementary and alternative medicines (adjusted OR: 5.59), willingness to get vaccinated again in the future (adjusted OR: 15.59), and prior negative perspectives (adjusted OR: 1.01) were the determinants with a significant negative association.
Discussion: In conclusion, the outcomes of the current work raise the possibility that health practitioners may be accountable for inappropriately prescribing vaccines to this demographic since 77% of the participants had a favorable attitude toward vaccination. These findings could serve as a springboard for creating targeted immunization efforts to raise vaccination coverage against vaccine-preventive diseases among celiac disease patients.
Keywords: COVID-19; Pakistan; celiac disease; policy; vaccination hesitancy; vaccine-preventable diseases.
Copyright © 2023 Rehman, Rehman and Holy.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Vaccination Status and Attitudes towards Vaccines in a Cohort of Patients with Celiac Disease.Vaccines (Basel). 2022 Jul 27;10(8):1199. doi: 10.3390/vaccines10081199. Vaccines (Basel). 2022. PMID: 36016087 Free PMC article.
-
COVID-19 Vaccine: A Survey of Hesitancy in Patients with Celiac Disease.Vaccines (Basel). 2021 May 16;9(5):511. doi: 10.3390/vaccines9050511. Vaccines (Basel). 2021. PMID: 34065654 Free PMC article.
-
A qualitative insight into the perceptions and COVID-19 vaccine hesitancy among Pakistani pharmacists.Hum Vaccin Immunother. 2022 Dec 31;18(1):2031455. doi: 10.1080/21645515.2022.2031455. Epub 2022 Feb 22. Hum Vaccin Immunother. 2022. PMID: 35192781 Free PMC article.
-
Addressing vaccine hesitancy and resistance for COVID-19 vaccines.Int J Nurs Stud. 2022 Jul;131:104241. doi: 10.1016/j.ijnurstu.2022.104241. Epub 2022 Apr 1. Int J Nurs Stud. 2022. PMID: 35489108 Free PMC article. Review.
-
Vaccine Preventable Disease and Vaccine Hesitancy.Med Clin North Am. 2023 Nov;107(6):979-987. doi: 10.1016/j.mcna.2023.05.012. Epub 2023 Jul 11. Med Clin North Am. 2023. PMID: 37806729 Review.
Cited by
-
Vaccine Efficacy and Safety in Patients with Celiac Disease.Vaccines (Basel). 2024 Nov 26;12(12):1328. doi: 10.3390/vaccines12121328. Vaccines (Basel). 2024. PMID: 39771990 Free PMC article. Review.
-
Psychological dynamics of pandemic resilience: a tale of two cultures.J Pharm Policy Pract. 2023 Dec 27;17(1):2291509. doi: 10.1080/20523211.2023.2291509. eCollection 2024. J Pharm Policy Pract. 2023. PMID: 38234996 Free PMC article.
-
SARS-CoV-2 Vaccination Coverage in Italian Children with Celiac Disease.J Clin Med. 2024 Sep 30;13(19):5851. doi: 10.3390/jcm13195851. J Clin Med. 2024. PMID: 39407910 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical